Correlation Between Monopar Therapeutics and 29278DAA3
Specify exactly 2 symbols:
By analyzing existing cross correlation between Monopar Therapeutics and ENEL CHILE S, you can compare the effects of market volatilities on Monopar Therapeutics and 29278DAA3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of 29278DAA3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and 29278DAA3.
Diversification Opportunities for Monopar Therapeutics and 29278DAA3
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Monopar and 29278DAA3 is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and ENEL CHILE S in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ENEL CHILE S and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with 29278DAA3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ENEL CHILE S has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and 29278DAA3 go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and 29278DAA3
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 13.61 times more return on investment than 29278DAA3. However, Monopar Therapeutics is 13.61 times more volatile than ENEL CHILE S. It trades about 0.39 of its potential returns per unit of risk. ENEL CHILE S is currently generating about 0.03 per unit of risk. If you would invest 2,446 in Monopar Therapeutics on November 9, 2024 and sell it today you would earn a total of 2,265 from holding Monopar Therapeutics or generate 92.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Monopar Therapeutics vs. ENEL CHILE S
Performance |
| Timeline |
| Monopar Therapeutics |
| ENEL CHILE S |
Monopar Therapeutics and 29278DAA3 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and 29278DAA3
The main advantage of trading using opposite Monopar Therapeutics and 29278DAA3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, 29278DAA3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 29278DAA3 will offset losses from the drop in 29278DAA3's long position.| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
| 29278DAA3 vs. Marfrig Global Foods | 29278DAA3 vs. Uber Technologies | 29278DAA3 vs. SunOpta | 29278DAA3 vs. Where Food Comes |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |